Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$11.8M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 24 most recent Form 4 transactions.
| <0.1% |
| Open the original filing on SEC.gov |
| Nov 2 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 756 | $97.45 | $73.7K | <0.1% | Open the original filing on SEC.gov |
| Nov 2 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,442 | $96.70 | $236.1K | -0.3% | Open the original filing on SEC.gov |
| Nov 2 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 15,036 | $95.64 | $1.4M | -1.6% | Open the original filing on SEC.gov |
| Nov 2 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 6,466 | $94.77 | $612.8K | -0.7% | Open the original filing on SEC.gov |
| Nov 2 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 25,000 | $7.80 | $195K | +2.7% | Open the original filing on SEC.gov |
| Oct 1 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 200 | $84.78 | $17K | <0.1% | Open the original filing on SEC.gov |
| Oct 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 8,554 | $84.03 | $718.8K | -0.9% | Open the original filing on SEC.gov |
| Oct 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 16,246 | $83.40 | $1.4M | -1.7% | Open the original filing on SEC.gov |
| Oct 1 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 25,000 | $7.80 | $195K | +2.7% | Open the original filing on SEC.gov |
| Sep 15 | ORKA | Oruka Therapeutics, Inc. | SSELL | 2,452 | $95.71 | $234.7K | -0.3% | Open the original filing on SEC.gov |
| Sep 1 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 75,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 4,800 | $92.44 | $443.7K | -0.5% | Open the original filing on SEC.gov |
| Sep 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 63,596 | $91.90 | $5.8M | -6.4% | Open the original filing on SEC.gov |
| Sep 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 6,604 | $90.79 | $599.6K | -0.7% | Open the original filing on SEC.gov |
| Sep 1 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 75,000 | $7.80 | $585K | +8.1% | Open the original filing on SEC.gov |
| Jun 15 | ORKA | Oruka Therapeutics, Inc. | SSELL | 1,729 | $69.69 | $120.5K | -0.2% | Open the original filing on SEC.gov |
| Jun 9 | JBIO | Jade Biosciences, Inc. | AGRANT◆ | 34,843 | — | — | — | Open the original filing on SEC.gov |
| Mar 16 | ORKA | Oruka Therapeutics, Inc. | SSELL | 1,729 | $41.30 | $71.4K | -0.2% | Open the original filing on SEC.gov |
| Jan 23 | ORKA | Oruka Therapeutics, Inc. | AGRANT◆ | 306,700 | — | — | — | Open the original filing on SEC.gov |
| Jan 23 | ORKA | Oruka Therapeutics, Inc. | AGRANT | 76,700 | — | — | +9.0% | Open the original filing on SEC.gov |
| Apr 29, 2025 | JBIO | Jade Biosciences, Inc. | AGRANT◆ | 23,017 | — | — | — | Open the original filing on SEC.gov |